Przemyslaw Sapieha

This inventor holds 8 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 3 EPO patents. Top assignees: Rsem, Limited Partnership, Ecole Polytechnique. Active years: 2017-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Przemyslaw Sapieha. Retrieved from https://idiyas.com/inventor/przemyslaw-sapieha

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 8 (Patent Applications = 3)

% Patents Active = 100.0

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 3 (Patent Applications = 2)

Average Co-Inventor Count = 1.6

ph-index = 1

Forward Citations = 2(Granted Patents)

Location History:

Montreal, CA (2017)
Montréal, CA (2020 - 2023)
Beaconsfield, CA (2020 - 2024)

Company Filing History:

7 out of 14

Rsem, Limited Partnership

Years Active: 2017-2024

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12031137 - Compositions comprising SASP modulators and senescence attenuators and uses thereof for modulating cellular senescence (2024-07-09),

2. 11649292 - Compositions and methods for treating and preventing inflammation (2023-05-16),

3. 11268097 - Inhibition of SEMA3A in the prevention and treatment of ocular hyperpermeability (2022-03-08),

4. 11058575 - Method and system for delivering exogenous biomolecules into the eye and method for forming pores into target cells of an eye (2021-07-13),

5. 10766964 - Compositions and methods for treating and preventing inflammation (2020-09-08),

6. 10738122 - Compositions and methods for treating and preventing inflammation (2020-08-11),

7. 10612028 - Inhibition of SEMA3A in the prevention and treatment of ocular hyperpermeability (2020-04-07),

8. 9822367 - Inhibition of SEMA3A in the prevention and treatment of ocular hyperpermeability (2017-11-21),

Title: Przemyslaw Sapieha: A Pioneer in Innovation

Introduction:

Przemyslaw Sapieha, a visionary inventor hailing from Beaconsfield, CA, is a man whose passion for innovation knows no bounds. With a portfolio boasting 7 patents, Sapieha continues to push the boundaries of technology and inspire the next generation of inventors.

Latest Patents:

Sapieha's latest patents showcase his groundbreaking work in the field of healthcare. His inventions focus on treating and preventing inflammation, as well as inhibiting SEMA3A activity to prevent ocular vascular hyperpermeability. These innovative compositions and methods are revolutionizing the way we approach healthcare and disease prevention.

Career Highlights:

Throughout his illustrious career, Sapieha has made significant contributions to companies such as RSEM Limited Partnership and Ecole Polytechnique. His innovative spirit and commitment to excellence have helped shape the future of technology in these organizations, setting new standards for innovation and invention.

Collaborations:

Sapieha has had the privilege of working alongside esteemed colleagues such as Normand Beaulieu and Michel Meunier. Together, they have collaborated on groundbreaking projects that have paved the way for new advancements in the field of healthcare and technology.

Conclusion:

In conclusion, Przemyslaw Sapieha's dedication to innovation and his relentless pursuit of excellence continue to leave a lasting impact on the world of technology. His pioneering work serves as a beacon of inspiration for aspiring inventors, driving them to push the boundaries of what is possible and shape the future of innovation.

Profile summary based on public USPTO records.